News & Articles

These models aim to accelerate treatment development prior to clinical trials

The test will be available for qualified laboratories across the European Union by the end of May

Plus, top tips to maintain water quality for your experiments

The MicronJet microneedle device to enable the development of a safe, effective and affordable vaccine

Leinco Technologies will co-develop a rapid, point of care, immunodiagnostic test for the detection of the SARS-CoV-2 virus responsible for COVID-19

Visitors to the virtual event can also experience continuous production from powders to the finished capsule with the specially developed X-key principle

The German-based biotech company specializes in process development for recombinant vaccines

Comprehensive turnkey system based on LabVantage LIMS platform allows laboratories to implement COVID-19 Biobanking, testing and research

Automatable, magnetic bead-based, ready-made reagents based on solid phase reversible immobilization technology

The STELLARIS, designed to empower researchers to drive progress in science, is confocal microscopy re-imagined

Discover the X-ray diffraction system that helps a leading provider of sheet aluminum provide high-quality materials and product advances

Learn how one immunology lab upgraded its cell counter to discriminate cells in a mixed population and streamline viability counts

Join this expert webinar to find out about applications for cell-based therapies and biologics using advanced high-throughput flow cytometry

Join this webinar to discover how cytometry can be used to monitor immune responses to new therapeutics and how the Maxpar Direct Immune Profiling System can help meet the demands of your COVID-19 research

Join this webinar to find out more about a powerful method of establishing etiology and pathogenesis of viral disease

Free white paper compares the pros and cons of various standard methods

The company is offering technical and scientific support along with supply chain continuity and instrument contributions

Following regulatory approval, the first clinical trial of the coronavirus vaccine candidates is said to commence in late April

Pioneering new class of diagnostic product will transform fight against pandemic